# DaVita (DVA) — News

DVA · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/dva/news

## Recent headlines

- **Important** — [BofA 3Q trading revenue ex. DVA $5.06B, est. $5.41B](https://www.ainvest.com/news/bofa-3q-trading-revenue-dva-5-06b-est-5-41b-2610) — AInvest Wire, Oct 14, 2026
- [Nuwellis - Expected to become Atrility's exclusive U.S. distributor after pilot](https://www.ainvest.com/news/nuwellis-expected-atrility-exclusive-distributor-pilot-2608) — AInvest Wire, Aug 25, 2026
  Nuwellis, Inc. (Nasdaq: NUWE) has entered into a collaboration with DaVita (NYSE: DVA) to pilot its Aquadex ultrafiltration therapy in select U.S. markets, marking a significant step in the company’s commercial strategy. The pilot program, set to launch by the end of Q3 2026 and run through May 31,…
- [Berkshire Hathaway reduces KR, COF, NUE, Ally, DVA in 2Q: 13F](https://www.ainvest.com/news/berkshire-hathaway-reduces-kr-cof-nue-ally-dva-2q-13f-2608) — AInvest Wire, Aug 14, 2026
  Berkshire Hathaway's second-quarter 2026 portfolio adjustments, as disclosed in its SEC Form 13F filing , reflect a continued shift in strategic focus under the leadership of CEO Greg Abel. Among the notable reductions were stakes in Kroger (KR), Capital One Financial (COF), Nucor (NUE), Ally…
- [Davita shares fall 15.3% after co flags lower revenue per treatment, reaffirms annual forecast](https://www.ainvest.com/news/davita-shares-fall-15-3-flags-revenue-treatment-reaffirms-annual-forecast-2608) — AInvest Wire, Aug 5, 2026
- [Davita Inc: BofA Global Research raises price objective to $170.00 from $145.00](https://www.ainvest.com/news/davita-bofa-global-research-raises-price-objective-170-00-145-00-2608) — AInvest Wire, Aug 5, 2026

## Similar Stocks

- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock
- [COR](https://www.lighthorse.io/tickers/cor) — Cencora, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock
- [ALGN](https://www.lighthorse.io/tickers/algn) — Align Technology, Inc. - Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).